Current Status of Group A Streptococcal Vaccine Development
Group A streptococci (GAS) are ubiquitous human pathogens that cause a wide spectrum of clinical syndromes. The acute infections range from uncomplicated pharyngitis, cellulitis, and pyoderma to necrotizing fasciitis, sepsis, pneumonia, and streptococcal toxic shock syndrome. The non-suppurative sequelae that may follow GAS infections are acute rheumatic fever (ARF) and post-streptococcal glomerulonephritis (PSGN). The burden of disease caused by GAS in economically developed and developing countries is significant. The search for a safe and effective vaccine to prevent GAS infections and their complications has been ongoing for more than 80 years. This chapter details the worldwide burden of disease, the obstacles encountered in vaccine development, current vaccine strategies and an update on the clinical development of M protein-based vaccines.
KeywordsRheumatic Fever Necrotizing Fasciitis Rheumatic Heart Disease Acute Rheumatic Fever Streptococcal Toxic Shock Syndrome
Unable to display preview. Download preview PDF.
- Kawabata S, Kunitomo E, Terao Y, Nakagawa I, Kikuchi K, Totsuka K, and Hamada S. (2001). Systemic and mucosal immunizations with fibronectin-binding protein FBP54 induce protective immune responses against Streptococcus pyogenes challenge in mice. Infect Immun, 69:924–930.PubMedCrossRefGoogle Scholar
- McNeil SA, Halperin SA, Langley JM, Smith B, Warren A, Sharratt GP, Baxendale DM, Reddish MA, Hu MC, Stroop SD, Linden J, Fries LF, Vink PE, and Dale JB. (2005). Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers. Clin Infect Dis, 41:1114–1122.PubMedCrossRefGoogle Scholar
- Stollerman GH. (1975). Rheumatic Fever and Streptococcal Infection. Grune and Stratton, New York, NY.Google Scholar
- WHO. (1992). WHO programme for the prevention of rheumatic fever/rheumatic heart disease in 16 developing countries: report from Phase I (1986–90). WHO Cardiovascular Diseases Unit and principal investigators. In Bull World Health Organ, Vol. 70, pp. 213–218.Google Scholar